Christopher Crank to Humans
This is a "connection" page, showing publications Christopher Crank has written about Humans.
Connection Strength
0.139
-
Comparison of outcomes from daptomycin or linezolid treatment for vancomycin-resistant enterococcal bloodstream infection: A retrospective, multicenter, cohort study. Clin Ther. 2010 Sep; 32(10):1713-9.
Score: 0.019
-
Evaluation of a low, weight-based dose of rasburicase in adult patients for the treatment or prophylaxis of tumor lysis syndrome. J Oncol Pharm Pract. 2011 Sep; 17(3):147-54.
Score: 0.019
-
Evaluation of pharmacy-implemented medication reconciliation directed at antiretroviral therapy in hospitalized HIV/AIDS patients. Ann Pharmacother. 2010 Jan; 44(1):222-3.
Score: 0.018
-
Evaluation of the relationship between opioid exposure in extremely low birth weight infants in the neonatal intensive care unit and neurodevelopmental outcome at 2 years. Early Hum Dev. 2016 Jan; 92:29-32.
Score: 0.007
-
Treatment outcomes with cefazolin versus oxacillin for deep-seated methicillin-susceptible Staphylococcus aureus bloodstream infections. Antimicrob Agents Chemother. 2015 Sep; 59(9):5232-8.
Score: 0.007
-
A multicentre evaluation of the effectiveness and safety of high-dose daptomycin for the treatment of infective endocarditis. J Antimicrob Chemother. 2013 Dec; 68(12):2921-6.
Score: 0.006
-
Multicenter study of high-dose daptomycin for treatment of enterococcal infections. Antimicrob Agents Chemother. 2013 Sep; 57(9):4190-6.
Score: 0.006
-
Effectiveness and feasibility of pharmacist-led admission medication reconciliation for geriatric patients. J Pharm Pract. 2012 Apr; 25(2):136-41.
Score: 0.005
-
Carbapenem stewardship: does ertapenem affect Pseudomonas susceptibility to other carbapenems? A review of the evidence. Int J Antimicrob Agents. 2012 Jan; 39(1):11-5.
Score: 0.005
-
High-dose daptomycin for treatment of complicated gram-positive infections: a large, multicenter, retrospective study. Pharmacotherapy. 2011 Jun; 31(6):527-36.
Score: 0.005
-
An evaluation of hepatotoxicity and nephrotoxicity of liposomal amphotericin B (L-AMB). J Med Toxicol. 2011 Mar; 7(1):12-5.
Score: 0.005
-
Impact of the implementation of a sepsis protocol for the management of fluid-refractory septic shock: A single-center, before-and-after study. Clin Ther. 2010 Jul; 32(7):1285-93.
Score: 0.005
-
Timely administration of antivirals for pandemic (H1N1) 2009 influenza. Clin Infect Dis. 2010 May 15; 50(10):1428-9.
Score: 0.005
-
The effect of time to antifungal therapy on mortality in Candidemia associated septic shock. Am J Ther. 2009 Nov-Dec; 16(6):508-11.
Score: 0.005
-
Clinical pharmacist competencies. Pharmacotherapy. 2008 Jun; 28(6):806-15.
Score: 0.004
-
Antibiotic therapy of methicillin-resistant Staphylococcus aureus in critical care. Crit Care Clin. 2008 Apr; 24(2):249-60, vii-viii.
Score: 0.004
-
Efficacy of ertapenem for consolidation therapy of extended-spectrum beta-lactamase-producing gram-negative infections: a case series report. Ann Pharmacother. 2008 Feb; 42(2):207-12.
Score: 0.004
-
Faropenem medoxomil. Ann Pharmacother. 2008 Jan; 42(1):80-90.
Score: 0.004
-
Daptomycin for the treatment of gram-positive bacteremia and infective endocarditis: a retrospective case series of 31 patients. Pharmacotherapy. 2006 Mar; 26(3):347-52.
Score: 0.004
-
Use of daptomycin to treat drug-resistant Gram-positive bone and joint infections. Curr Med Res Opin. 2005 Dec; 21(12):1923-6.
Score: 0.003